Search - tctmd.com

Displaying 101 - 120 of 167

Sort: Relevancy | Date

Point-of-Care hs-cTn Tests for MI Rule-out Could Save Time, Resources

News Daily News

Point-of-Care hs-cTn Tests for MI Rule-out Could Save Time, Resources

Yael L. Maxwell

December 01, 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

News Conference News AHA 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

Yael L. Maxwell

November 14, 2021

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

News Daily News

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

November 01, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

October 12, 2021

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

News Daily News

HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients

Yael L. Maxwell

October 12, 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

News Conference News HFSA 2021

Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF

Michael O'Riordan

September 14, 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

Getting More Women in CV Research Will ‘Take a Village’

News Daily News

Getting More Women in CV Research Will ‘Take a Village’

Yael L. Maxwell

August 09, 2021

COVID-19: TCTMD’s Daily Dispatch for August Week 2

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 2

August 08, 2021

J-Curve for Alcohol and AF Risk? UK Biobank Offers ‘Glimmer of Hope’

News Conference News HRS 2021

J-Curve for Alcohol and AF Risk? UK Biobank Offers ‘Glimmer of Hope’

July 28, 2021

COVID-19: TCTMD’s Daily Dispatch for June Week 5

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 5

June 28, 2021

Help for Evaluating Coronary Disease in People With High-Risk Jobs

News Daily News

Help for Evaluating Coronary Disease in People With High-Risk Jobs

June 15, 2021

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

News Daily News

Anticoagulation Use Quickly Rose to Meet COVID-19 Need

June 14, 2021

COVID-19: TCTMD’s Daily Dispatch for June Week 3

News Daily News

COVID-19: TCTMD’s Daily Dispatch for June Week 3

June 11, 2021

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

Pneumonia in HF Patients Is Common, Lethal, and Preventable

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

April 19, 2021

VTE Related to SARS-CoV-2 Infection Less of a Problem in Outpatients

News Daily News

VTE Related to SARS-CoV-2 Infection Less of a Problem in Outpatients

April 06, 2021

Complicated Pregnancies and CVD Risk: Cardiologists Can Be Part of Solution

News Daily News

Complicated Pregnancies and CVD Risk: Cardiologists Can Be Part of Solution

March 30, 2021

Acute Exposure to Air Pollution Can Trigger MI-Related Death

News Daily News

Acute Exposure to Air Pollution Can Trigger MI-Related Death

January 18, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.